Numeral Limited (JSE:XII)

Market Cap	125.12M -43.7%
Revenue (ttm)	34.99M +30.0%
Net Income	1.27M -52.6%
EPS	0.01 -95.3%
Shares Out	n/a
PE Ratio	98.41
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15,000
Open	28.00
Previous Close	28.00
Day's Range	28.00 - 28.00
52-Week Range	9.00 - 90.00
Beta	0.01
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 5, 2026

About Numeral

Numeral Limited, an investment holding company, engages in biotech, health and pharmaceutical, and financial businesses in Mauritius. It also provides legal support, human resources, technology support, financial services, corporate finance, and marketing, as well as business acquisition solutions. The company was formerly known as Go Life International Limited and changed its name to Numeral Limited in December 2023. Numeral Limited was incorporated in 2010 and is based in Phoenix, Mauritius.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2010
• Country: Mauritius
• Stock Exchange: Johannesburg Stock Exchange
• Ticker Symbol: XII

Financial Performance

In fiscal year 2026, Numeral's revenue was $2.20 million, an increase of 29.98% compared to the previous year's $1.69 million. Earnings were $79,939, a decrease of -52.64%.

Financial numbers in USD

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 30, 2026

Data Sources Report a data error